Treatment for adults with moderate to severe psoriasis approved by FDA
A treatment for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or…
A treatment for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or…
Top line results from a clinical trial treating breast cancer patients with radiation dermatitis (RD)…
More than half of patients treated for psoriasis with an intravenous injection showed no visible…
Ilya Pharma, a Swedish clinical stage biopharma company focused on delivering local immunotherapies to patients,…
The U.S. Food and Drug Administration (FDA) has accepted the filing of a biologic license…
A new call for new therapies to treat skin diseases has been launched by global…
U.S. gene therapy company Krystal Biotech, Inc, has submitted a Biologics License Application (BLA) to…